CapsoVision (CV) Liabilities and Shareholders Equity (2024 - 2026)

CapsoVision has disclosed Liabilities and Shareholders Equity across 3 years of filings, most recently posting $18.6 million for Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity rose 94.5% year-over-year to $18.6 million; the TTM figure through Jun 2026 stood at $71.9 million (up 173.02% YoY), while the FY2025 annual figure was $18.2 million, up 8.1% from the prior year.
• Liabilities and Shareholders Equity came in at $18.6 million for Q2 2026 at CapsoVision, up from $18.2 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $25.7 million in Q3 2025 to a low of $9.5 million in Q2 2025.
• Average Liabilities and Shareholders Equity over 3 years is $17.7 million, with a median of $18.2 million recorded in 2025.
• Year-over-year, Liabilities and Shareholders Equity rose 8.1% in 2025 and soared 94.5% in 2026.
• Over 3 years, Liabilities and Shareholders Equity stood at $16.8 million in 2024, then climbed by 8.1% to $18.2 million in 2025, then advanced by 2.23% to $18.6 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $18.6 million in Q2 2026, $18.2 million in Q4 2025, and $25.7 million in Q3 2025.